FDA Special Government Employees: Consultants
Guests
Arthritis Advisory Committee:
Raymond A. Dionne, D.D.S., Ph.D.
Clinical Director, NIH, NIDCR, PNMB
Building 10, 1 N-117
10 Center Drive
Bethesda, MD 20892
Janet D. Elashoff, Ph.D.
Director, Division of Biostatistics
Cedars-Sinai Medical Center
8700 Beverly Boulevard
Los Angeles, California 90048
Clifford J. Woolf, M.D.
Neural Plasticity Research Group
Department of Anesthesia & Critical Care
Massachusetts General Hospital
149 13th Street, Room 4309
Charlestown MA 02129
Anesthetic and Life Support
Advisory Committee:
Michael Ashburn, M.D., M.P.H.
University of Utah
Department of Anesthesiology
Pain Research and Management Center
615 Arapeen Drive, Suite 200
Salt Lake City, Utah 84108
Nathaniel P. Katz, M.D.
212 Winding Brook Road
New Rochelle, NY 10804
Mitchell B. Max, M.D.
National Institutes of Health
Building 10, Room 3C-405
Bethesda, MD 20982-1258
NonPrescription Drugs Advisory Committee:
Frank F. Davidoff, M.D.
Editor Emeritus, Annals of Internal Medicine
143 Garden Street
Wethersfield, CT 06109
Alastair Wood, M.D.
Medical Research Building
Room 550 MRB1
Vanderbilt University School of Medicine
Nashville, Tennessee 37232-6602
Industry Representative:
Charles H. McLeskey, M.D.
Global Medical Director/Global Marketing Director
Anesthesia/Sedation
Abbott Laboratories – HPD/GPRD
Department 96R, Building LFCP4-4
200 Abbott Park Road
Abbott Park, IL 60064-6229
Guests:
David Borenstein, M.D.
Arthritis and Rheumatism Associates, Inc.
2021 K Street NW, Suite 300
Washiington, D.C. 20006
John T. Farrar, M.D., MSCE
University of Pennsylvania
Room 816 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104-6021
Vibeke Strand, M.D.
Biopharmaceutical Consultant
Clinical Professor, Division of Immunology
Stanford University.
306 Ramona Road
Portola Valley, CA 94028
July 29-30, 2002